Why is Frontier Biotechnologies, Inc. (China) ?
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of 25.68% and Operating profit at 2.96% over the last 5 years
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 82.09%, its profits have risen by 56.6%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Frontier Biotechnologies, Inc. (China) for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Frontier Biotechnologies, Inc. (China)
107.61%
3.06
73.57%
China Shanghai Composite
17.07%
1.58
14.20%
Quality key factors
Factor
Value
Sales Growth (5y)
25.68%
EBIT Growth (5y)
2.96%
EBIT to Interest (avg)
-95.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.33
Sales to Capital Employed (avg)
0.08
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.15
EV to EBIT
-20.21
EV to EBITDA
-24.42
EV to Capital Employed
7.63
EV to Sales
37.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-37.75%
ROE (Latest)
-13.14%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
7What is working for the Company
NET PROFIT(HY)
Higher at CNY -115.17 MM
ROCE(HY)
Highest at -15.74%
RAW MATERIAL COST(Y)
Fallen by -54.39% (YoY
NET SALES(Q)
Highest at CNY 44.73 MM
-11What is not working for the Company
PRE-TAX PROFIT(Q)
Lowest at CNY -62.03 MM
NET PROFIT(Q)
Lowest at CNY -62.03 MM
EPS(Q)
Lowest at CNY -0.17
Here's what is working for Frontier Biotechnologies, Inc. (China)
Net Sales
Highest at CNY 44.73 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Raw Material Cost
Fallen by -54.39% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Frontier Biotechnologies, Inc. (China)
Pre-Tax Profit
At CNY -62.03 MM has Fallen at -87.16%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -62.03 MM has Fallen at -87.16%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Pre-Tax Profit
Lowest at CNY -62.03 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY -62.03 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY -0.17
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)






